As of 2025-12-28, the Relative Valuation of Royalty Pharma PLC (RPRX) is 32.33 USD. This relative valuation is based on P/E multiples. With the latest stock price at 39.22 USD, the upside of Royalty Pharma PLC based on Relative Valuation is -17.6%.
The range of the Relative Valuation is 25.18 - 38.83 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 20.6x | 19.9x |
| Forward P/E multiples | 20.1x - 21.8x | 21.5x |
| Fair Price | 25.18 - 38.83 | 32.33 |
| Upside | -35.8% - -1.0% | -17.6% |
| Date | P/E |
| 2025-12-26 | 29.60 |
| 2025-12-24 | 29.62 |
| 2025-12-23 | 29.72 |
| 2025-12-22 | 29.32 |
| 2025-12-19 | 29.13 |
| 2025-12-18 | 29.00 |
| 2025-12-17 | 28.91 |
| 2025-12-16 | 28.96 |
| 2025-12-15 | 29.07 |
| 2025-12-12 | 28.97 |
| 2025-12-11 | 29.29 |
| 2025-12-10 | 28.87 |
| 2025-12-09 | 28.74 |
| 2025-12-08 | 29.18 |
| 2025-12-05 | 29.98 |
| 2025-12-04 | 29.54 |
| 2025-12-03 | 29.88 |
| 2025-12-02 | 29.83 |
| 2025-12-01 | 30.11 |
| 2025-11-28 | 30.20 |
| 2025-11-26 | 30.06 |
| 2025-11-25 | 29.84 |
| 2025-11-24 | 30.00 |
| 2025-11-21 | 29.37 |
| 2025-11-20 | 28.97 |
| 2025-11-19 | 29.17 |
| 2025-11-18 | 29.78 |
| 2025-11-17 | 29.55 |
| 2025-11-14 | 29.55 |
| 2025-11-13 | 29.98 |
| 2025-11-12 | 29.87 |
| 2025-11-11 | 29.40 |
| 2025-11-10 | 29.08 |
| 2025-11-07 | 29.10 |
| 2025-11-06 | 30.77 |
| 2025-11-05 | 30.50 |
| 2025-11-04 | 28.55 |
| 2025-11-03 | 28.15 |
| 2025-10-31 | 28.33 |
| 2025-10-30 | 27.88 |
| 2025-10-29 | 27.67 |
| 2025-10-28 | 27.48 |
| 2025-10-27 | 28.12 |
| 2025-10-24 | 28.12 |
| 2025-10-23 | 27.81 |
| 2025-10-22 | 27.80 |
| 2025-10-21 | 28.28 |
| 2025-10-20 | 27.64 |
| 2025-10-17 | 27.93 |
| 2025-10-16 | 27.42 |